Electron impact mass spectroscopic studies on mouse retinal fatty acids:

Ophthalmic Research

Volumn 42, Issue 1, 2009, Pages 9-14

  Hegde, K R ^a   Varma, S D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetic retina; Fatty acids; Gas chromatography mass spectrometry of fatty acids

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; FATTY ACID ESTER; LIPID; OLEIC ACID; PALMITIC ACID; STEARIC ACID;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FATTY ACID ANALYSIS; GAS CHROMATOGRAPHY; LIPID COMPOSITION; LIPID PEROXIDATION; LIPID STORAGE; LIPIDOSIS; LIPOFUSCINOSIS; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; FATTY ACIDS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MASS SPECTROMETRY; MICE; RETINA;

EID: 66149117435     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000219679     Document Type: Article

References (30)

1. Bresnick GH: Diabetic retinopathy viewed as a neurosensory disorder. Arch Ophthalmol 1986;104:989-990.
2. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-412.
3. Ceriello A, Giugliano D, Quatraro A, Dello Russo P, Lefèbvre PJ: Metabolic control may influence the increased superoxide generation in diabetic serum. Diabet Med 1991;8: 540-542.
4. Altomare E, Vendemiale G, Chicco D, Procacci V, Cirelli F: Increased lipid peroxi-dation in type 2 poorly controlled diabetic patients. Diabetes Metab 1992;18:264-271.
5. Richardson HB: The capacity to oxidize carbohydrate as determined by the respiratory quotient. Monatsschr Kinderheilkd 1925;24: 588-593.
6. Richardson HB, Levine SZ: Clinical calorimetry. XXXIX. Exercise and the respiratory quotient in diabetes. J Biol Chem 1925; 66:161-183.
7. Monnier VM, Stevens VJ, Cerami A: Nonenzymatic glycosylation, sulphydryl oxidation and high molecular weight aggregation of lens proteins in experimental sugar cataracts. J Exp Med 1979;50:1098-1117.
8. Blakytny R, Harding JJ: Glycation (non-enzymatic glycosylation) inactivates glutathione reductase. Biochem J 1992;288:303-307.
9. Wolff SP, Crabbe MJC, Thornalley PJ: The autooxidation of glyceraldehydes and other simple monosaccharides. Experientia 1984; 40:244-246.
10. Zhao W, Devamanoharan PS, Henein M, Ali AH, Varma SD: Diabetes-induced biochemical changes in rat lens: attenuation of cata-ractogenesis by pyruvate. Diabetes Obes Metab 2000; 2: 165-174.
11. Kowluru RA, Kern TS, Engerman RL, Armstrong D: Abnormalities of retinal metabolism in diabetes or experimental galactos-emia. III. Effects of antioxidants. Diabetes 1996;45:1233-1237.
12. Fliesler SJ, Anderson RE: Chemistry and metabolism of lipids in the vertebrate retina; in Holma n RT (ed): Prog ress i n Lipid Research. Oxford, Pergamon Press, 1983, vol 22, pp 79-131.
13. Wurtman RJ, Wurtman JJ (eds): Nutrition and the Brain. New York, Raven, 1990, vol 8, pp 1-24.
14. Benolken RM, Anderson RE, Wheeler TG: Membrane fatty acids associated with the electrical response in visual excitation. Science 1973;182:1253-1254.
15. Neuringer M, Connor WE, Lin DS, Barstad L, Luck S: Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci USA 1986; 83: 4021-4025.
16. Bicknell IR, Darrow R, Barsalou L, Fliesler SJ, Organisciak DT: Alterations in retinal rod outer segment fatty acids and light-damage susceptibility in P23H rats. Mol Vis 2002; 8:333-408.
17. Kim HY, Akbar M, Lau A, Edsall L: Inhibition of neuronal apoptosis by docosahexaenoic acid (22: 6n-3): role of phosphatidylserine in antiapoptotic effect. J Biol Chem 2000; 275:35215-35223.
18. Hegde KR, Varma SD: Prevention of oxidative stress to the retina by pyruvate: a preliminary report. Ophthalmologica 2008; 222:194-198.
19. Futterman S, Sturtevant R, Kupfer C: Effect of alloxan diabetes on the fatty acid composition of the retina. Invest Ophthalmol 1969;8: 542-544.
20. Hegde KR, Henein MG, Varma SD: Establishment of the mouse as a model animal for the study of diabetic cataracts. Ophthalmic Res 2003;35:12-18.
21. Shimasaki H, Phillips FC, Privett OS: Direct transesterification of lipids in mammalian tissue for fatty acid analysis via dehydration with 2,2'-dimethoxypropane. J Lipid Res 1977;18:540-543.
22. Hegde KR, Henein MG, Varma SD: Establishment of mouse as an animal model for study of diabetic cataracts: biochemical studies. Diabetes Obes Metab 2003;5:113-119.
23. Kowluru RA, Tang J, Kern TS: Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001; 50:1938-1942.
24. Peluffo RO, Ayala S, Brenner RR: Metabolism of fatty acids of the linoleic acid series in testicles of diabetic rats. Am J Physiol 1970; 218:669-673.
25. Varma SD, Kinoshita JH: Absence of cata-rac ts in mice with congenit a l hy perglycemia . Exp Eye Res 1974;19:577-582.
26. Like AA, Appel MC, Williams MR, Rossini A: Streptozotocin-induced pancreatic insulitis in mice. Lab Invest 1978; 38:470-485.
27. Flakoll P, Carlson MG, Cherrington A: Physiologic action of insulin; in LeRoith D, Taylor SI, Olefsky JM (eds): Diabetes Mellitus: A Fundamental and Clinical Text. Philadelphia, Lippincott-Raven, 1996, pp 124-126.
28. Bonen A, Parolin ML, Steinberg GR, et al: Triacylgycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/ CD36. FASEB J 2004;18:1144-1146.
29. Goodpaster BH, Wolf D: Skeletal muscle lipid accumulation in obesity, insulin resistance and type 2 diabetes. Pediatr Diabetes 2004;5:219-226.
30. Altman DG: Practical Statistics for Medical Research. London, Chapman & Hall, 1991, pp 179-228.